Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.
Interim report May – October 2019
Oasmia launches the ovarian cancer treatment drug Apealea® in Sweden, Denmark and Finland
Watch clip, including interviews with our Chief Medical Officer and Chief Business Officer.
We uses cookies in order to optimize your use of our website. Read more about cookies.
